header-23.jpg
Events

APCRC - Q Seminar Series

Featuring the research of Dr Michael Doran of QUT's Institute of Health and Biomedical Innovation.
Event Type Seminar
When Aug 16, 2012
from 08:30 PM to 10:30 PM
Where Russell Strong Auditorium
Contact Name
Contact Phone +61 7 3176 1894
Add event to calendar vCal
iCal

Michael Doran

Dr Michael Doran

Stem Cell Therapies Laboratory - Group Leader

Institute of Health and Biomedical Innovation

Queensland University of Technology

"Micromarrows - a potential platform for studying bone metastasis"

Dr Michael Doran was awarded his PhD in 2006.  Since, he has completed two postdoctoral fellowships split between the University of Queensland (UQ) and the Mater Medical Research Institute (MMRI).  During this time he filed two patents, lectured a 4th year Engineering Subject for three years at UQ, mentored postgraduate students, published a number of high-impact papers (7 A*), won UniQuest Trailblazer Innovation awards in 3 consecutive years, won 4 external competitive grants, and presented internationally at a number of conferences.

In 2010, he relocated to QUT where he was awarded the prestigious QUT Vice Chancellor’s Fellowship.  Within QUT’s Institute of Health and Biomedical Innovation (IHBI) Dr Doran set up the Stem Cell Therapies Laboratory.  He is the direct supervisor of 4 PhD students focused on the development of stem cell-based therapies.  his team will grow to 6 PhD students in late 2012.  Since 2009 he has published 19 articles, two of which are book chapters, had over 114 citations and has brought in over $500,000 worth of external funding.

 

 

Dr Varinder Jeet

Dr Varinder Jeet

Postdoctoral Research Fellow

Australian Prostate Cancer Research Centre - Queensland

IHBI, QUT

YKL40 as a therapeutic target for the treatment of Castration Resistant Prostate Cancer"

Dr Varinder Jeet completed his PhD studies from the University of New South Wales, Sydney in 2009. He received a Masters degree in Biotechnology from Punjabi University, India. He started his PhD in 2005 after receiving the Sydney Foundation of Medical Research Postgraduate Scholarship. During his PhD, he investigated various aspects of prostate cancer (PC) including development of a suitable model for prostate cancer progression, study of mechanisms underlying advanced PC and targeted gene therapy mediated approaches to curb the growth and proliferation of PC cells.

Soon after completing his PhD, he moved to Brisbane to work on the dendritic cell based cancer immunotherapy at the Mater Hospital, Brisbane. His current project at APCRC - Q involves the identification and targeting of various molecular markers that underlie the progression of prostate cancer towards androgen independence.